Department of Oncology and Hematology CCM

Projects

• mTOR- Inhibition beim Mammakarzinom
• Angiogenesis and osteoclast activation in multiple myeloma
• Antiviral screening of microalgae compounds
• Antiviral screening of microalgea compounds
• Bedeutung biochemischer Marker des Knochenmetabolismus für Diagnostik und Therapie von Knochenmetastasen
• comparison of immediate vs. deferred empirical antifungal treatment with voriconazole in high-risk patients
• CZOL446DE01
• Detection of Polyomavirus in blood and urine of patients after stem cell transplantation.
• Die Wirkung der kombinierten Gabe von Imatinib und TZD18 auf die bcl-abl-positiven Leukämiezellen
• Early diagnosis of lung cancer - molecular alterations in bronchial lavage and BAL
• Effects of combination therapy of glitazone with imatinib on tumor cells in vitro
• Effects of PPAR gamma ligands on human glioblastoma cells.
• Entwicklung von Adenovirusvektoren
• HER2/neu in serum for prognosis and prediction of chemotherapy in breast cancer
• Isavuconazole vs. Caspofungin for treatment of candidemia and invasive Candida infections
• Klinische FG KFO 105/2-1 TP 1
• Molekulare Diagnostik invasiver Pilzinfektionen bei immunsupprimierten Patienten
• Multiresistenz bei Zytostatika
• NHRs and Cancer
• Outcome research in breast cancer
• PPARy and.Osteoclasts
• PPARy ligand as a novel therapy for acute lymphocytic leukemia: rationale and mechanisms
• Proteasome inhibitors in cancer treatment
• PS-341 Velcade
• Quality of life studies in cancer
• RANKL-OPG
• Register systemischer Mykosen in Dt.
• Research grant AIM
• Stem cell expansion

If the list does not contain any entry, the request was executed without results